Good to see some buying coming in. Market definitely not pricing this correctly. Currently with an EV of $35m and minimum first year revenues of ~$6-8m, looks like a steal at these levels.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential